Finance

Lists
Why is NXTCL down 9.37%?
Dive Deeper
NXTCL:STO
NextCell Pharma AB
SEK 0.22
-9.37%
(-0.022) 1D
11-р сарын 20, 17:00:00 (GMT+1)  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for NXTCL...
Open
SEK 0.24
High
SEK 0.24
Low
SEK 0.20
Mkt. cap
27.49 сая
Avg. vol.
1.00 сая
Volume
1.44 сая
52-wk high
SEK 1.78
52-wk low
SEK 0.20
EPS
-SEK 0.45
Shares outstanding
111.39 сая
No. of employees
21
Open
SEK 0.24
High
SEK 0.24
Low
SEK 0.20
Mkt. cap
27.49 сая
Avg. vol.
1.00 сая
Volume
1.44 сая
52-wk high
SEK 1.78
52-wk low
SEK 0.20
EPS
-SEK 0.45
Shares outstanding
111.39 сая
No. of employees
21
News stories
From web sources and news partners
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees21
Founded2014 оны 3-р сарын 19
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 оны 5-р сар
2025 оны 8-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.26 сая
1.83 сая
2.78 сая
3.03 сая
Cost of goods sold
2.11 сая
1.93 сая
1.82 сая
1.90 сая
Cost of revenue
2.11 сая
2.20 сая
1.82 сая
1.90 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.69 сая
13.20 сая
10.88 сая
12.21 сая
Operating expense
10.50 сая
9.11 сая
11.43 сая
12.86 сая
Total operating expenses
12.62 сая
15.72 сая
13.25 сая
14.76 сая
Operating income
-10.35 сая
-13.90 сая
-10.46 сая
-11.73 сая
Other non operating income
-
-1.00
-
-
EBT including unusual items
-10.27 сая
-13.79 сая
-10.39 сая
-11.68 сая
EBT excluding unusual items
-10.27 сая
-13.79 сая
-10.39 сая
-11.68 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
201.47 мян
-120.48 мян
-81.33 мян
37.36 мян
Net income
-10.27 сая
-13.79 сая
-10.39 сая
-11.68 сая
Net profit margin
-454.15%
-342.26%
-373.25%
-384.77%
Earnings per share
-
-
-
-
Interest and investment income
82.25 мян
162.24 мян
79.47 мян
50.96 мян
Interest expense
-
-1.59 мян
-1.19 мян
-188.00
Net interest expenses
82.25 мян
109.02 мян
78.28 мян
50.78 мян
Depreciation and amortization charges
615.41 мян
638.32 мян
625.24 мян
616.94 мян
EBITDA
-9.74 сая
-13.26 сая
-9.84 сая
-11.11 сая
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google аппс